HDAC9 and non-small cell lung carcinoma: In another study in NSCLC and neuroblastoma cell lines, Hajji et al. employed HDAC inhibitors to investigate the drug resistance mechanisms and found that both the deacetylase hMOF and its target H4K16ac play key roles in sensitivity of drug resistant calls [30].